Tumour length measured on PET-CT predicts the most appropriate stage-dependent therapeutic approach in oesophageal cancer (original) (raw)

Access this article

Log in via an institution

Subscribe and save

• Get 10 units per month
• Download Article/Chapter or eBook
• 1 Unit = 1 Article or 1 Chapter
• Cancel anytime Subscribe now

Buy Now

Price excludes VAT (USA)
Tax calculation will be finalised during checkout.

Instant access to the full article PDF.

References

1. Eloubeidi MA, Desmond R, Arguedas MR, Reed CE, Wilcox CM (2002) Prognostic factors for the survival of patients with esophageal carcinoma in the U.S.: the importance of tumor length and lymph node status. Cancer 95:1434–1443
   Article PubMed Google Scholar
2. Gill PG, Denham JW, Jamieson GG, Devitt PG, Yeoh E, Olweny C (1992) Patterns of treatment failure and prognostic factors associated with the treatment of esophageal carcinoma with chemotherapy and radiotherapy either as sole treatment or followed by surgery. J Clin Oncol 10:1037–1043
   PubMed CAS Google Scholar
3. Igaki H, Kato H, Tachimori Y, Sato H, Daiko H, Nakanishi Y (2001) Prognostic evaluation for squamous cell carcinomas of the lower thoracic esophagus treated with three-field lymph node dissection. Eur J Cardiothorac Surg 19:887–893
   Article PubMed CAS Google Scholar
4. Urba SG, Orringer MB, Turrisi A, Iannettoni M, Forastiere A, Strawderman M (2001) Randomized trial of preoperative chemoradiation versus surgery alone in patients with locoregional esophageal carcinoma. J Clin Oncol 19:305–313
   PubMed CAS Google Scholar
5. Griffiths EA, Brummell Z, Gorthi G, Pritchard SA, Welch IM (2006) Tumor length as a prognostic factor in esophageal malignancy: univariate and multivariate survival analyses. J Surg Oncol 15:258–267
   Article Google Scholar
6. Rice TW, Zuccaro G Jr, Adelstein DJ, Rybicki LA, Blackstone EH, Goldblum JR (1998) Esophageal carcinoma: depth of tumor invasion is predictive of regional lymph node status. Ann Thorac Surg 65:787–792
   Article PubMed CAS Google Scholar
7. Rice TW, Adelstein DJ (1997) Precise clinical staging allows treatment modification of patients with esophageal carcinoma. Oncology (Williston Park) 11:58–62
   CAS Google Scholar
8. Sherman CA, Turrisi AT, Wallace MB, Reed CE (2002) Locally advanced esophageal cancer. Curr Treat Options Oncol 3:475–485
   Article PubMed Google Scholar
9. Cerfolio RJ, Bryant AS, Ohja B, Bartolucci AA, Eloubeidi MA (2005) The accuracy of endoscopic ultrasonography with fine-needle aspiration, integrated positron emission tomography with computed tomography, and computed tomography in restaging patients with esophageal cancer after neoadjuvant chemoradiotherapy. J Thorac Cardiovasc Surg 129:1232–1241
   Article PubMed Google Scholar
10. Hagen JA, DeMeester SR, Peters JH, Chandrasoma P, DeMeester TR (2001) Curative resection for esophageal adenocarcinoma: analysis of 100 en bloc esophagectomies. Ann Surg 234:520–530
    Article PubMed CAS Google Scholar
11. Walsh TN, Noonan N, Hollywood D, Kelly A, Keeling N, Hennessy TP (1996) A comparison of multimodal therapy and surgery for esophageal adenocarcinoma. N Engl J Med 335:462–467
    Article PubMed CAS Google Scholar
12. Mamede M, El Fakhri G, Abreu-e-Lima P, Gandler W, Nosé V, Gerbaudo VH (2007) Pre-operative estimation of esophageal tumor metabolic length in FDG-PET images with surgical pathology confirmation. Ann Nucl Med 21:553–562
    Article PubMed Google Scholar
13. Konski A, Doss M, Milestone B, Haluszka O, Hanlon A, Freedman G, Adler L (2005) The integration of 18-fluoro-deoxy-glucose positron emission tomography and endoscopic ultrasound in the treatment-planning process for esophageal carcinoma. Int J Radiat Oncol Biol Phys 61:1123–1128
    PubMed Google Scholar
14. Choi JY, Jang HJ, Shim YM, Kim K, Lee KS, Lee KH, Choi Y, Choe YS, Kim BT (2004) 18F-FDG PET in patients with esophageal squamous cell carcinoma undergoing curative surgery: prognostic implications. J Nucl Med 45:1843–1850
    PubMed Google Scholar
15. Ott K, Weber WA, Lordick F, Becker K, Busch R, Herrmann K, Wieder H, Fink U, Schwaiger M, Siewert JR (2006) Metabolic imaging predicts response, survival, and recurrence in adenocarcinomas of the esophagogastric junction. J Clin Oncol 24:4692–4698
    Article PubMed Google Scholar
16. Wieder HA, Beer AJ, Lordick F, Ott K, Fischer M, Rummeny EJ, Ziegler S, Siewer JR, Schwaiger M (2005) Comparison of changes in tumor metabolic activity and tumor size during chemotherapy of adenocarcinomas of the esophagogastric junction. J Nucl Med 46:2029–2034
    PubMed CAS Google Scholar
17. Dickson GH, Singh KK, Escofet X, Kelley K (2001) Validation of a modified GTNM classification in peri-junctional oesophago-gastric carcinoma and its use as a prognostic indicator. Eur J Surg Oncol 27:641–644
    Article PubMed CAS Google Scholar
18. Korst RJ, Rusch VW, Venkatraman E, Bains MS, Burt ME, Downey RJ, Ginsberg RJ (1998) Proposed revision of the staging classification for esophageal cancer. J Thorac Cardiovasc Surg 115:660–669
    Article PubMed CAS Google Scholar
19. Rice TW, Blackstone EH, Rybicki LA, Adelstein DJ, Murthy SC, DeCamp MM, Goldblum JR (2003) Refining esophageal cancer staging. J Thorac Cardiovasc Surg 125:1103–1113
    Article PubMed Google Scholar
20. Bhutani MS, Barde CJ, Markert RJ, Gopalswamy N (2002) Length of esophageal cancer and degree of luminal stenosis during upper endoscopy predict T stage by endoscopic ultrasound. Endoscopy 34:461–463
    Article PubMed CAS Google Scholar
21. Van Dam J (1994) Endosonographic evaluation of the patient with esophageal carcinoma. Chest Surg Clin N Am 4:269–284
    PubMed Google Scholar
22. Byrne MF, Jowell PS (2002) Gastrointestinal imaging: endoscopic ultrasound. Gastroenterology 122:1631–1648
    Article PubMed Google Scholar
23. Halvorsen RA Jr, Magruder-Habib K, Foster WL Jr, Roberts L Jr, Postlethwait RW, Thompson WM (1986) Esophageal cancer staging by CT: long-term follow-up study. Radiology 161:147–151
    PubMed Google Scholar

Download references